CN111500531A - Method for in vitro long-term culture of chicken PGCs - Google Patents
Method for in vitro long-term culture of chicken PGCs Download PDFInfo
- Publication number
- CN111500531A CN111500531A CN202010410510.1A CN202010410510A CN111500531A CN 111500531 A CN111500531 A CN 111500531A CN 202010410510 A CN202010410510 A CN 202010410510A CN 111500531 A CN111500531 A CN 111500531A
- Authority
- CN
- China
- Prior art keywords
- pgcs
- cells
- cultured
- culture
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003822 preparative gas chromatography Methods 0.000 title claims abstract description 99
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 25
- 238000000338 in vitro Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000007774 longterm Effects 0.000 title claims description 15
- 238000012258 culturing Methods 0.000 claims abstract description 7
- 239000001963 growth medium Substances 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 40
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 26
- 239000003636 conditioned culture medium Substances 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 14
- 229960004857 mitomycin Drugs 0.000 claims description 13
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 8
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 6
- 210000002257 embryonic structure Anatomy 0.000 claims description 6
- 230000005012 migration Effects 0.000 claims description 6
- 238000013508 migration Methods 0.000 claims description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 5
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 claims description 4
- 230000004069 differentiation Effects 0.000 claims description 4
- 230000002710 gonadal effect Effects 0.000 claims description 4
- 102000055151 human KITLG Human genes 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 230000035755 proliferation Effects 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- 229930182816 L-glutamine Natural products 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- 239000007995 HEPES buffer Substances 0.000 claims description 2
- 101000942966 Mus musculus Leukemia inhibitory factor Proteins 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 230000006862 enzymatic digestion Effects 0.000 claims description 2
- 239000002777 nucleoside Substances 0.000 claims description 2
- 125000003835 nucleoside group Chemical group 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 2
- 108010076089 accutase Proteins 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 239000012894 fetal calf serum Substances 0.000 claims 1
- 235000013330 chicken meat Nutrition 0.000 description 18
- 210000002149 gonad Anatomy 0.000 description 10
- 101000634050 Homo sapiens Histone-lysine N-methyltransferase, H3 lysine-36 specific Proteins 0.000 description 8
- 238000010609 cell counting kit-8 assay Methods 0.000 description 7
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 108010087230 Sincalide Proteins 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 229930002330 retinoic acid Natural products 0.000 description 4
- 229960001727 tretinoin Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 210000002242 embryoid body Anatomy 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 101100366935 Caenorhabditis elegans sto-2 gene Proteins 0.000 description 1
- 101100366936 Caenorhabditis elegans sto-3 gene Proteins 0.000 description 1
- 101100464679 Gallus gallus POU5F3 gene Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
- -1 NANOG Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001172 blastoderm Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000003783 cell cycle assay Methods 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 238000003235 crystal violet staining Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 238000010232 migration assay Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A method for culturing chicken PGCs in vitro for a long time includes such steps as separating chicken PGCs, purifying and culturing the PGCs, systematically comparing the addition of feeder layer, the treatment of feeder layer and the addition ratio of BR L to culture medium, and culturing chicken PGCs in vitro for a long time.
Description
Technical Field
The invention relates to a method for in vitro long-term culture of chicken PGCs, belonging to the technical field of zootechnics and cytology.
Background
Since Dubois reported in 1969, several studies have been conducted on chicken PGCs, and several basic growth factors and specific growth factors L IF, bFGF and hSCF have been found to maintain PGC survival, proliferation and growth in vitro, and in addition, in combination with growth factors, conditioned medium and feeder cells, PGC can remain proliferative and undifferentiated in vitro for long periods of time, but there are few available methods for long-term culture of PGCs in vitro, which greatly affects long-term studies and utilization of PGC.
Disclosure of Invention
Although many research researches on separation methods, in vitro culture and the like of chicken PGCs are carried out, no systematic and comprehensive culture system is available for in vitro long-term culture of PGCs, which greatly limits research and application of poultry PGCs in aspects of germ cell development, genetic resource protection and the like.
Therefore, the invention provides a method for in vitro long-term culture of chicken PGCs, and the compound culture system can be used for carrying out long-term in vitro culture on PGCs, so that research and application of poultry PGCs in the aspects of germ cell development, genetic resource protection and the like can be fully carried out.
In order to achieve the purpose of the invention, the technical scheme adopted by the invention is as follows:
the chicken PGCs are obtained by separation, and then the PGCs are purified and cultured, systematic comparison is made on the aspects of the PGC culture method, whether a feeding layer is added or not, the feeding layer treatment method, the addition proportion of a BR L conditioned medium and the like, and finally the method for in-vitro long-term culture of the chicken PGCs is determined.
Specifically, the method comprises the following steps:
separating chicken PGCs from gonads of 4.5-5.5 d embryo chicken embryos, and purifying the PGCs by a differential wall-pasting method. The culture methods of PGCs were systematically compared in terms of whether or not a feeder layer was added, the method of treating the feeder layer, the ratio of the addition of the conditioned medium, and the like.
The results showed that PGCs were cultured for about 300 days on feeder cells treated with 20. mu.g/ml mitomycin C for 2 hours and in a complex culture system in factor medium supplemented with 50% BR L conditioned medium, and that PGCs cultured for a long period in this culture system maintained high proliferative capacity without transformation, and their pluripotency, migratory ability and differentiative ability.
The invention has the following beneficial effects:
the method for culturing chicken PGCs in vitro for a long term is obtained through experiments such as respectively treating the feeder layer cells with mitomycin C with various concentrations (10, 15, 20 and 30 mug/ml) for different times (2, 3 and 4h) according to the addition of the feeder layer cells, adding BR L conditioned medium with different proportions (0%, 20%, 40%, 50%, 60% and 80%) into the culture medium, and the like.
In order to fully exert the value of PGC used as a transgenic tool and a bioreactor carrier and simultaneously more conveniently and effectively utilize the chicken gonad PGC, the invention researches the optimal culture system for culturing the chicken gonad PGC for a long time, thereby fully excavating the research value of the chicken gonad PGC and laying a solid foundation for later-stage PGC establishment and even production of transgenic chickens.
Drawings
FIG. 1 is a schematic diagram showing the isolation and culture of PGCs in the present invention;
in the figure: A-D are morphologies of the cultured PGCs;
a is that PGCs are separated at the 27 th embryonic stage (C arrow), and are subjected to primary culture together with chick embryo gonad stromal cells (B arrow) and blood cells (A arrow);
b is PGC aggregation for 3 days of primary culture (C arrow);
c is the growth of PGCs which are difficult to maintain by gonadal stromal cells after 7 days of primary culture (C arrow);
d is subculture of PGCs on mitomycin C treated feeder cells (C arrow);
e is the morphology of STO cells;
f is the morphology of BR L cells;
FIG. 2 shows a complex culture system for PGCs;
in the figure: a is the form of PGC with feeder cells and the form of PGC 5 days after no addition of bFGF;
b is the cell proliferation rate of PGC with feeder cells and 5 days after the addition of bFGF;
c is that when the cell fusion degree reaches 60%, mitomycin C with various concentrations (10, 15, 20 and 30g/ml) is respectively used for treating feeder layer cells for 2, 3 and 4 hours, and CCK-8 is used for detecting the influence of the mitomycin C treatment on cell proliferation and vitality;
d is the growth curve of STO cells treated with mitomycin C at different concentrations;
e morphology of mitomycin C treated STO cells at different concentrations;
f is the cell proliferation rate of PGCs supplemented with BR L Conditioned Medium (CM) and 5 days later without BR L conditioned medium;
g is a conditioned medium which is added into the culture medium in a proportion of 0%, 20%, 40%, 50%, 60% and 80%, and the proliferation rate and the activity of the PGCs are detected by CCK-8;
FIG. 3 shows that PGC cell lines maintain high proliferation potency without transformation
In the figure: a is a growth curve of PGCs separately cultured by the culture system;
b is ZW type chicken PGCs (female parent) metaphase (left) chromosome and karyotype (right), and the chromosome karyotype is still diploid;
C-E cell cycle analysis of freshly isolated PGCs (C), thawed PGCs (D), and long-term cultured PGCs (E);
f is the colony forming ability of PGCs; colony forming ability of hela cells (positive control) (top) and PGCs (bottom) at 1, 3, 5, 7 days was measured by soft agar method;
g is the number of clones measured by the soft agar method under a stereomicroscope after crystal violet staining;
h is RT-PCR analysis of telomerase reverse transcriptase in PGCs cultured in vitro (cultured for 15, 68, 180 and 268 days and thawed PGCs);
FIG. 4 shows that PGCs cultured for a long period of time have high pluripotency and differentiation potential;
in the figure, A-D are immunocytochemical analyses of cultured PGCs, and 180 days after the culture, immunohistochemical staining was performed with antibodies against SSEA-1(A), C-kit (B), cDAZ L (C) and Sox2(D), respectively
E is RT-PCR analysis of in vitro cultured PGCs (cultured for 15, 68, 180, 268 days and thawed) POUV, NANOG, DAZ L;
f is migration of the cultured PGCs to the crescent area of the reproductive system; approximately 3000 PGCs cultured for 200 days were labeled with PKH26 and then transferred to the subgerminal cavity of embryonic blastoderms; labeled cells (red) were detected in the crescentic region of reproduction;
g is gonad migration of the cultured PGCs; PKH 26-labeled PGCs on the left, and controls on the right; approximately 3000 PGCs cultured for 230 days were labeled with PKH26 and then injected into the blood vessels of recipient embryos at stages 14-17; detection of labeled cells in the embryonic gonads (red);
h isolating cells from gonads of PGCs labeled with PKH 26;
i is the formation of Embryoid Bodies (EB) of PGCs cultured for 248 days, and 2 mu mol/L of RA is used to induce PGCs cultured for a long time, and after 7 days, simple embryoid bodies (upper) grow and can continue to grow for 14 days (lower).
Detailed Description
A method for in vitro long-term culture of chicken PGCs comprises the following specific steps:
1. materials and methods
1.1 isolation, purification and culture of PGCs
Fertilized eggs (Babcock B300 strain; Yangzhou Rui agricultural technologies, Inc.) were incubated at 37 ℃ and 70% relative humidity. After 120H incubation, gonadal tissue was extracted from embryos at about H & H27 stage under a stereomicroscope with fine forceps, PGCs were isolated by enzymatic digestion, and cells were further purified by differential adherence.
PGCs were placed on a feeder layer of mitomycin C-treated STO and cultured in an incubator at 37 ℃ with 5% CO2 and 60-70% relative humidity, the medium consisted of KO-DMEM, and 10% Fetal Bovine Serum (FBS), 2.5% Chicken Serum (CS), 2mM L-glutamine, 1 × MEM nonessential amino acids, 1 × nucleosides, 1 × HEPES, 0.1mM β -mercaptoethanol, 5ng/ml human stem cell factor (hSCF), 10ng/ml basic fibroblast growth factor (bFGF) and 10ng/ml mouse leukemia inhibitory factor (L IF) were added to the medium.
1.2 treatment of feeder layers
In the incubator, STO was cultured in DMEM medium containing 10% FBS. To determine the optimal concentration for feeder cells, we treated STO 2, STO 3, and STO 4h with mitomycin C at various concentrations (10, 15, 20, and 30. mu.g/ml) after 60% confluence, and then examined cell viability using CCK-8 assay. To prevent excessive toxicity of mitomycin C, STO was subcultured on complete medium for at least 24h, after which the inactivated STO was used as a feeder layer for PGC.
1.3 preparation of conditioned Medium
BR L was cultured in KO-DMEM medium containing 10% FBS, 2mM L-glutamine, the medium was changed within 24h to remove debris and waste from the cells after passaging, conditioned medium was collected, filtered, and then added to PGC medium after 2 days of medium change, and to test the optimum addition ratio of BR L conditioned medium, we then added 0%, 20%, 40%, 50%, 60%, 80% conditioned medium, respectively, and tested the viability of the cultured PGCs with CCK-8.
1.4 cryopreservation and thawing of PGCs
The cultured PGCs were collected and resuspended in cryoprotectant containing 10% DMSO and 90% FBS, each tube was frozen 2 × 106-1×107The individual cell cryovials were placed in a freezing container with isopropanol and stored overnight in a freezer at-80 ℃. The sample in the cryovial was heated in a water bath at 37 ℃ and then shaken until the ice crystals disappeared. The antifreeze was diluted 10-fold in 1 minute.
1.5 cell viability assay
To measure cell viability, cell counting kit 8(CCK-8) was used according to the instructions, cells were seeded into 96-well plates, after approximately 24h of culture, treated according to the instructions CCK-8(10 μ l) was added per well, incubated for 1.5 hours, and then cell viability was measured, absorbance was measured at 450nm with a Microplate reader, cell viability was calculated according to the formula (control OD-treated OD)/(control OD-blank OD) × 100%, assay was repeated 3 times.
1.6 immunofluorescence
Cultured PGCs were seeded into 24-well plates with treated feeder layers and incubated for about 24 h.cells were fixed in freshly prepared 4% paraformaldehyde-PBS for 20min, then washed 3 times with Phosphate Buffered Saline (PBS), then samples were treated with 0.5% Triton X-100 permeabilization buffer for 20min after 3 washes with PBS, cells were blocked with 1% bovine serum albumin blocking buffer for 30min, then incubated with primary antibody (anti-SSEA-1, c-kit, Sox2, cDAZ L) diluted to 5-20 μ g/m L in BSA at 4 ℃ overnight protected from light, after 3 washes with PBS containing 0.05% Tween-20 (PBS-T), cells were incubated with secondary antibody conjugated with fluorescent dye for 1h at room temperature, finally cells were counterstained with DAPI for 10min and analyzed under fluorescent microscope.
1.7 cell cycle analysis
To analyze cell cycle and apoptosis of freshly isolated PGCs, thawed PGCs and long-term cultured PGCs, a cell cycle and apoptosis assay kit (Beyotime) was used according to the instructions. Harvested cells were fixed with 70% ethanol overnight and then incubated with RNase for 5 min. After addition of Propidium Iodide (PI) at 37 ℃ away from light for 30min, the DNA content was analyzed using a FACSCalibur flow cytometer over 24 h.
1.8 Soft agar assay
1.2% melted agar was cooled to 37 ℃ and mixed with 2 × DMEM containing 20% fetal bovine serum as the basal layer, the final concentration of agarose being 0.6%. cells suspended in 0.3% agarose (1000 cells/m L) were then seeded onto the basal layer (an appropriate amount of medium was added to keep moist). 7d the colony formation was observed under a microscope, and the visible colonies were stained with crystal violet and counted under a stereomicroscope.
1.9RT-PCR analysis
Total RNA of the cultured PGCs was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA) (cultured for 15, 68, 180 and 268 days and thawed), and the First Strand cDNA library was reverse transcribed using Transcriptor First-Strand cDNA Synthesis and the target cDNA was amplified by RT-PCR. The reaction involved 35 cycles (95 ℃ 20s, 60 ℃ 40s, 72 ℃ 1 min). GAPDH expression was used as a reference to normalize expression levels.
1.10 karyotyping
The cultured PGC was mixed with colchicine (final concentration 0.25. mu.g/ml) at 37 ℃ in 5% CO2After 4h, the cells were harvested, centrifuged and resuspended in 0.075M KCl preheated to 37 ℃. After incubation at 37 ℃ for 15min, the cells were pelleted again, and the cells were incubated with 3: 1 methanol: fix with acetic acid and wash 3 times with fixative. Finally, the cell suspension was dropped onto a cooled glass slide and stained with Giemsa.
1.11 gonadal migration test
Long-term cultured PGCs were used for migration assays. To determine the migration of PGCs into the crescentic region of reproduction, cells were labeled with PKH26 red fluorescent cell linker minikit (Sigma), 3000 cells per egg were transferred into the subgerminal cavity of the stage X recipient embryo. Incubation of the Parafilm-sealed recipient eggs was continued for 24h until stage 6, and the crescentic area of the in vitro embryos was observed under a fluorescent microscope. PKH 26-labeled PGCs were injected into the dorsal aorta of stage 14-17 embryos to analyze PGC migration to the gonads. It was sealed with Parafilm and incubated to stage 30 and the gonads were observed under a fluorescent microscope.
1.12RA Induction assay
PGCs cultured by induction with Retinoic Acid (RA) were differentiated into germ cells to test their differentiation ability, and the PGCs were cultured in a feeder-free complete medium containing 2. mu.M/M L RA, and their morphological changes were observed by an inverted microscope.
1.13 statistical analysis
All results are expressed as mean values. Statistical analysis and graphical representation were performed using GraphPad Prism 6 software. P values less than 0.05 were considered significant, and P values less than 0.01 were considered very significant.
As can be seen from FIGS. 1 and 2, the chicken PGCs were cultured in vitro for a long period in a complex culture system of STO feeder cells treated with mitomycin C at 20. mu.g/ml for 2 hours and factor medium supplemented with 50% BR L conditioned medium.
As can be seen from FIGS. 3 and 4, PGCs cultured in vitro for a long period of time still have high proliferative capacity without transformation, and still have high pluripotency and differentiation capacity.
Claims (5)
1. A method for long-term in vitro culture of chicken PGCs is characterized in that chicken PGCs are obtained by separation, and then the PGCs are purified and cultured; as for the culture of PGCs, the feeder layer is treated and a conditioned medium is added, and PGCs can be cultured in the complex culture system for a long period of time, maintain high proliferation ability without transformation, and maintain pluripotency, migration ability and differentiation ability.
2. The method of claim 1, wherein the step of isolating and purifying the PGCs comprises:
incubating the fertilized egg at 37 ℃ and 70% relative humidity; after 120H incubation, gonadal tissue was extracted from H & H27 stage embryos using fine forceps under a stereomicroscope, PGCs were isolated by enzymatic digestion, and cells were further purified by differential adherence.
3. The method of claim 2, wherein the culturing of the PGCs comprises:
placing PGCs on a feeder layer of mitomycin C-treated STO, and culturing in an incubator at 37 deg.C, 5% CO2, and 60-70% relative humidity;
the culture medium is composed of KO-DMEM, and 10% fetal calf serum, 2.5% chicken serum, 2mM L-glutamine, 1 × MEM nonessential amino acids, 1 × nucleosides, 1 × HEPES, 0.1mM β -mercaptoethanol, 5ng/ml human stem cell factor, 10ng/ml basic fibroblast growth factor and 10ng/ml mouse leukemia inhibitory factor are added into the culture medium;
in subculture, the medium in which the PGCs were cultured was changed every day, and the cells were dissociated with Accutase and passaged onto newly treated feeder cells.
4. The method of claim 3, wherein the feeder layer is treated by: feeder cells were treated with 20. mu.g/ml mitomycin C for 2 h.
5. The method of claim 4, wherein the ratio of BR L conditioned medium to total medium is 50% BR L conditioned medium.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010410510.1A CN111500531A (en) | 2020-05-15 | 2020-05-15 | Method for in vitro long-term culture of chicken PGCs |
AU2021101223A AU2021101223A4 (en) | 2020-05-15 | 2021-03-09 | METHOD FOR LONG-TERM IN VITRO CULTURE OF CHICKEN PGCs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010410510.1A CN111500531A (en) | 2020-05-15 | 2020-05-15 | Method for in vitro long-term culture of chicken PGCs |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111500531A true CN111500531A (en) | 2020-08-07 |
Family
ID=71873345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010410510.1A Pending CN111500531A (en) | 2020-05-15 | 2020-05-15 | Method for in vitro long-term culture of chicken PGCs |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111500531A (en) |
AU (1) | AU2021101223A4 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114410572A (en) * | 2022-01-24 | 2022-04-29 | 成都思澍生物科技有限公司 | Method for quickly separating high-purity primordial germ cells from chick embryo blood |
CN115088679A (en) * | 2022-07-20 | 2022-09-23 | 扬州大学 | Method for constructing chimera chicken breed conservation by utilizing gonad cells |
CN116855444A (en) * | 2023-07-06 | 2023-10-10 | 扬州大学 | Method for establishing chicken primordial germ cell monoclonal cell line |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999006533A1 (en) * | 1997-08-04 | 1999-02-11 | University Of Massachusetts A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof |
WO2000008132A1 (en) * | 1998-08-03 | 2000-02-17 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof |
WO2000047717A1 (en) * | 1999-02-11 | 2000-08-17 | Hanmi Pharm. Co., Ltd. | Avian pluripotent embryonic germ cell line |
WO2001011019A1 (en) * | 1999-08-09 | 2001-02-15 | North Carolina State University | Method of producing an undifferentiated avian cell culture using avian primordial germ cells |
US20060174362A1 (en) * | 2005-02-01 | 2006-08-03 | Origen Therapeutics, Inc. | Long-term culture of avian primordial germ cells (PGCs) |
CN1821389A (en) * | 2006-03-02 | 2006-08-23 | 扬州大学 | External Cultivating method for bird primordial germ cell |
CN101504339A (en) * | 2009-02-24 | 2009-08-12 | 扬州大学 | Method for detecting early archaeocyte of quail |
CN103827293A (en) * | 2011-06-29 | 2014-05-28 | 通用医疗公司 | Compositions and methods for enhancing bioenergetic status in female germ cells |
WO2016091272A1 (en) * | 2014-12-12 | 2016-06-16 | Central Veterinary Research Laboratory | System and method for establishing a long-term culture of avian primordial germ cells and uses thereof |
-
2020
- 2020-05-15 CN CN202010410510.1A patent/CN111500531A/en active Pending
-
2021
- 2021-03-09 AU AU2021101223A patent/AU2021101223A4/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999006533A1 (en) * | 1997-08-04 | 1999-02-11 | University Of Massachusetts A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof |
WO2000008132A1 (en) * | 1998-08-03 | 2000-02-17 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof |
WO2000047717A1 (en) * | 1999-02-11 | 2000-08-17 | Hanmi Pharm. Co., Ltd. | Avian pluripotent embryonic germ cell line |
WO2001011019A1 (en) * | 1999-08-09 | 2001-02-15 | North Carolina State University | Method of producing an undifferentiated avian cell culture using avian primordial germ cells |
US20060174362A1 (en) * | 2005-02-01 | 2006-08-03 | Origen Therapeutics, Inc. | Long-term culture of avian primordial germ cells (PGCs) |
CN1821389A (en) * | 2006-03-02 | 2006-08-23 | 扬州大学 | External Cultivating method for bird primordial germ cell |
CN101504339A (en) * | 2009-02-24 | 2009-08-12 | 扬州大学 | Method for detecting early archaeocyte of quail |
CN103827293A (en) * | 2011-06-29 | 2014-05-28 | 通用医疗公司 | Compositions and methods for enhancing bioenergetic status in female germ cells |
WO2016091272A1 (en) * | 2014-12-12 | 2016-06-16 | Central Veterinary Research Laboratory | System and method for establishing a long-term culture of avian primordial germ cells and uses thereof |
Non-Patent Citations (11)
Title |
---|
KONG LL等: "Long-term in vitro culture and preliminary establishment of chicken primordial germ cell lines", 《PLOS ONE》 * |
孔令琳: "鸡原始生殖细胞体外长期培养与建系初探", 《中国畜牧兽医学会家禽学分会第十八次全国家禽学术讨论会》 * |
常国斌等: "鹌鹑早期原始生殖细胞迁移和聚集规律的研究", 《畜牧兽医学报》 * |
李志腾等: "鸡生殖干细胞中Piwi基因的干涉效率", 《中国农业科学》 * |
李碧春等: "鸡生殖干细胞研究现状与展望", 《中国家禽》 * |
李碧春等: "鸡胚不同发育时期原始生殖细胞的分离方法", 《动物学报》 * |
王娟等: "鸡胚胎生殖细胞在鼠胚成纤维细胞饲养层上的生长", 《生物技术通讯》 * |
秦洁等: "细胞因子对鸡胚胎原始生殖细胞(EPGCs)增殖的影响", 《中国生物工程杂志》 * |
秦洁等: "鸡胚胎原始生殖细胞的体外培养", 《中国兽医学报》 * |
秦洁等: "鸡胚胎原始生殖细胞的培养和传代", 《动物学报》 * |
肖小等: "第28期鸡胚原始生殖细胞的冷冻保存与体外培养研究", 《西北农林科技大学学报(自然科学版)》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114410572A (en) * | 2022-01-24 | 2022-04-29 | 成都思澍生物科技有限公司 | Method for quickly separating high-purity primordial germ cells from chick embryo blood |
CN115088679A (en) * | 2022-07-20 | 2022-09-23 | 扬州大学 | Method for constructing chimera chicken breed conservation by utilizing gonad cells |
CN116855444A (en) * | 2023-07-06 | 2023-10-10 | 扬州大学 | Method for establishing chicken primordial germ cell monoclonal cell line |
Also Published As
Publication number | Publication date |
---|---|
AU2021101223A4 (en) | 2021-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021101223A4 (en) | METHOD FOR LONG-TERM IN VITRO CULTURE OF CHICKEN PGCs | |
JP5843775B2 (en) | Manipulation of osmolality to differentiate stem cells | |
Kala et al. | In vitro culture and morphological characterization of prepubertal buffalo (Bubalus bubalis) putative spermatogonial stem cell | |
CN102787092B (en) | Culture medium, cell culture kit and cell culture processes | |
CN102344906B (en) | Hair follicle stem cell separation culture method | |
CN103966159B (en) | Human plactnta Subaerial blue green algae and stem cell bank construction process thereof | |
CN113025565B (en) | Establishment of salmon sperm primitive stem cell line and induced differentiation method thereof | |
CN112251399B (en) | Separation method and culture medium for ricefield eel reproductive stem cells | |
CN104911144B (en) | The isolated culture method of one breeder germinal crescent source PGCs | |
CN105385651B (en) | Inductive pluripotent stem cells Induction of committed differentiation is method and the liver cell of liver cell | |
CN115747140A (en) | Method for inducing differentiation of chicken embryonic stem cells to generate primordial germ cells | |
CN100540659C (en) | A kind of method and special culture media thereof of cultivating mouse embryo stem cell | |
JP5620905B2 (en) | Cell death induction method for pluripotent stem cells and differentiated cells other than cardiomyocytes | |
CN104694462A (en) | Method for directionally inducing to differentiate embryonic stem cell into hepatocyte | |
CN112544613A (en) | Pluripotent stem cell cryopreservation liquid, application thereof and cryopreservation method | |
CN111304156A (en) | Induced trophoblast stem cell and preparation method and application thereof | |
CN103305459A (en) | Method for conversion of porcine spermatogonia stem cell into embryonic stem cell-like cell by small molecule induction | |
CN104140951B (en) | A kind of method set up and cultivate people induced multi-potent stem cell | |
CN115261301B (en) | In-vitro induction and culture method for retinal pigment epithelial cells | |
CN114276984B (en) | Method for transdifferentiating female germ stem cells into functional sperm and application | |
CN102358892A (en) | Manufacturing method for embryoid bodies of bovine induced pluripotent stem (iPS) cells | |
Freed et al. | Characteristics of cell lines from haploid and diploid anuran embryos | |
CN110331162B (en) | Aortic dissection specific induced pluripotent stem cell and disease model application | |
Xiao et al. | Establishing a human pancreatic stem cell line and transplanting induced pancreatic islets to reverse experimental diabetes in rats | |
CN113652393A (en) | Method for improving pluripotency of bovine embryonic stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200807 |
|
RJ01 | Rejection of invention patent application after publication |